HighTower Advisors
TRIL

HighTower Advisors’s Trillium Therapeutics Inc. TRIL Stock Holding History

HighTower Advisors’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,925
Closed -$117K – 3098
2021
Q1 		$117K Buy
+10,925
New +$117K ﹤0.01% 2708